Page 1 | Search Results | Clinical Cancer Research | American Association for Cancer Research

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Editor's Note: Therapeutic Targeting of ATP7B in Ovarian Carcinoma

Clin Cancer Res (2021) 27 (15): 4454.

https://doi.org/10.1158/1078-0432.CCR-21-2120

Published: 01 August 2021

View article titled, Editor's Note: Therapeutic Targeting of ATP7B in Ovarian Carcinoma

Journal Articles

Editor's Note: Biologic Effects of Platelet-Derived Growth Factor Receptor α Blockade in Uterine Cancer

Clin Cancer Res (2021) 27 (15): 4449.

https://doi.org/10.1158/1078-0432.CCR-21-2115

Published: 01 August 2021

View article titled, Editor's Note: Biologic Effects of Platelet-Derived Growth Factor Receptor α Blockade in Uterine Cancer

Journal Articles

Correction: Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability

Hailing Yang, Weiqun Mao, Cristian Rodriguez-Aguayo, Lingegowda S. Mangala, Geoffrey Bartholomeusz, Lakesla R. Iles, Nicholas B. Jennings, Ahmed Ashour Ahmed, Anil K. Sood, Gabriel Lopez-Berestein, Zhen Lu, Robert C. Bast, Jr

Clin Cancer Res (2020) 26 (18): 5050.

https://doi.org/10.1158/1078-0432.CCR-20-3198

Published: 15 September 2020

View article titled, Correction: Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability

Journal Articles

6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers

Clin Cancer Res (2019) 25 (18): 5702–5716.

https://doi.org/10.1158/1078-0432.CCR-18-3448

Published: 13 September 2019

View article titled, 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers

Includes: Supplementary data

Journal Articles

Correction: Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy

Jyotsnabaran Halder, Aparna A. Kamat, Charles N. Landen, Jr, Liz Y. Han, Susan K. Lutgendorf, Yvonne G. Lin, William M. Merritt, Nicholas B. Jennings, Arturo Chavez-Reyes, Robert L. Coleman, David M. Gershenson, Rosemarie Schmandt, Steven W. Cole, Gabriel Lopez-Berestein, Anil K. Sood

Clin Cancer Res (2019) 25 (10): 3194.

https://doi.org/10.1158/1078-0432.CCR-19-1132

Published: 15 May 2019

View article titled, Correction: Focal Adhesion Kinase Targeting Using <em>In vivo</em> Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy

Journal Articles

Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability

Clin Cancer Res (2018) 24 (20): 5072–5084.

https://doi.org/10.1158/1078-0432.CCR-18-0504

Published: 15 October 2018

View article titled, Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability

Includes: Supplementary data

Journal Articles

Macrophages Facilitate Resistance to Anti-VEGF Therapy by Altered VEGFR Expression

Clin Cancer Res (2017) 23 (22): 7034–7046.

https://doi.org/10.1158/1078-0432.CCR-17-0647

Published: 14 November 2017

View article titled, Macrophages Facilitate Resistance to Anti-VEGF Therapy by Altered VEGFR Expression

Includes: Supplementary data

Journal Articles

Immunotherapy Targeting Folate Receptor Induces Cell Death Associated with Autophagy in Ovarian Cancer

Yunfei Wen, Whitney S. Graybill, Rebecca A. Previs, Wei Hu, Cristina Ivan, Lingegowda S. Mangala, Behrouz Zand, Alpa M. Nick, Nicholas B. Jennings, Heather J. Dalton, Vasudha Sehgal, Prahlad Ram, Ju-Seog Lee, Pablo E. Vivas-Mejia, Robert L. Coleman, Anil K. Sood

Clin Cancer Res (2015) 21 (2): 448–459.

https://doi.org/10.1158/1078-0432.CCR-14-1578

Published: 14 January 2015

View article titled, Immunotherapy Targeting Folate Receptor Induces Cell Death Associated with Autophagy in Ovarian Cancer

Includes: Multimedia, Supplementary data

Journal Articles

Biologic Effects of Platelet-Derived Growth Factor Receptor α Blockade in Uterine Cancer

Clin Cancer Res (2014) 20 (10): 2740–2750.

https://doi.org/10.1158/1078-0432.CCR-13-2507

Published: 14 May 2014

View article titled, Biologic Effects of Platelet-Derived Growth Factor Receptor α Blockade in Uterine Cancer

Includes: Supplementary data

Journal Articles

Cross-talk between EphA2 and BRaf/CRaf Is a Key Determinant of Response to Dasatinib

Clin Cancer Res (2014) 20 (7): 1846–1855.

https://doi.org/10.1158/1078-0432.CCR-13-2141

Published: 31 March 2014

View article titled, Cross-talk between EphA2 and BRaf/CRaf Is a Key Determinant of Response to Dasatinib

Includes: Supplementary data

Journal Articles

Targeting Src and Tubulin in Mucinous Ovarian Carcinoma

Clin Cancer Res (2013) 19 (23): 6532–6543.

https://doi.org/10.1158/1078-0432.CCR-13-1305

Published: 01 December 2013

View article titled, Targeting Src and Tubulin in Mucinous Ovarian Carcinoma

Includes: Supplementary data

Journal Articles

Metronomic Activity of CD44-Targeted Hyaluronic Acid-Paclitaxel in Ovarian Carcinoma

Sun Joo Lee, Sukhen C. Ghosh, Hee Dong Han, Rebecca L. Stone, Justin Bottsford-Miller, De Yue Shen, Edmond J. Auzenne, Alejandro Lopez-Araujo, Chunhua Lu, Masato Nishimura, Chad V. Pecot, Behrouz Zand, Duangmani Thanapprapasr, Nicholas B Jennings, Yu Kang, Jie Huang, Wei Hu, Jim Klostergaard, Anil K. Sood

Clin Cancer Res (2012) 18 (15): 4114–4121.

https://doi.org/10.1158/1078-0432.CCR-11-3250

Published: 30 July 2012

View article titled, Metronomic Activity of CD44-Targeted Hyaluronic Acid-Paclitaxel in Ovarian Carcinoma

Includes: Supplementary data

Journal Articles

EphA2 Targeted Chemotherapy Using an Antibody Drug Conjugate in Endometrial Carcinoma

Jeong-Won Lee, Rebecca L. Stone, Sun Joo Lee, Eun Ji Nam, Ju-Won Roh, Alpa M. Nick, Hee-Dong Han, Mian M.K. Shahzad, Hye-Sun Kim, Lingegowda S. Mangala, Nicholas B. Jennings, Shenlan Mao, John Gooya, Dowdy Jackson, Robert L. Coleman, Anil K. Sood

Clin Cancer Res (2010) 16 (9): 2562–2570.

https://doi.org/10.1158/1078-0432.CCR-10-0017

Published: 28 April 2010

View article titled, EphA2 Targeted Chemotherapy Using an Antibody Drug Conjugate in Endometrial Carcinoma

Includes: Supplementary data

Journal Articles

Therapeutic Targeting of ATP7B in Ovarian Carcinoma

Clin Cancer Res (2009) 15 (11): 3770–3780.

https://doi.org/10.1158/1078-0432.CCR-08-2306

Published: 01 June 2009

View article titled, Therapeutic Targeting of ATP7B in Ovarian Carcinoma

Includes: Supplementary data

Journal Articles

Estrous Cycle Modulates Ovarian Carcinoma Growth

Guillermo N. Armaiz-Pena, Lingegowda S. Mangala, Whitney A. Spannuth, Yvonne G. Lin, Nicholas B. Jennings, Alpa M. Nick, Robert R. Langley, Rosemarie Schmandt, Susan K. Lutgendorf, Steven W. Cole, Anil K. Sood

Clin Cancer Res (2009) 15 (9): 2971–2978.

https://doi.org/10.1158/1078-0432.CCR-08-2525

Published: 30 April 2009

View article titled, Estrous Cycle Modulates Ovarian Carcinoma Growth

Journal Articles

Surgical Stress Promotes Tumor Growth in Ovarian Carcinoma

Jeong-Won Lee, Mian M.K. Shahzad, Yvonne G. Lin, Guillermo Armaiz-Pena, Lingegowda S. Mangala, Hee-Dong Han, Hye-Sun Kim, Eun Ji Nam, Nicholas B. Jennings, Jyotsnabaran Halder, Alpa M. Nick, Rebecca L. Stone, Chunhua Lu, Susan K. Lutgendorf, Steve W. Cole, Anna E. Lokshin, Anil K. Sood

Clin Cancer Res (2009) 15 (8): 2695–2702.

https://doi.org/10.1158/1078-0432.CCR-08-2966

Published: 15 April 2009

View article titled, Surgical Stress Promotes Tumor Growth in Ovarian Carcinoma

Journal Articles

Biobehavioral Influences on Matrix Metalloproteinase Expression in Ovarian Carcinoma

Susan K. Lutgendorf, Donald M. Lamkin, Nicholas B. Jennings, Jesusa M.G. Arevalo, Frank Penedo, Koen DeGeest, Robert R. Langley, Joseph A. Lucci, III, Steve W. Cole, David M. Lubaroff, Anil K. Sood

Clin Cancer Res (2008) 14 (21): 6839–6846.

https://doi.org/10.1158/1078-0432.CCR-08-0230

Published: 03 November 2008

View article titled, Biobehavioral Influences on Matrix Metalloproteinase Expression in Ovarian Carcinoma

Journal Articles

Dual Targeting of Endothelial Cells and Pericytes in Antivascular Therapy for Ovarian Carcinoma

Chunhua Lu, Aparna A. Kamat, Yvonne G. Lin, William M. Merritt, Charles N. Landen, Tae Jin Kim, Whitney Spannuth, Thiru Arumugam, Liz Y. Han, Nicholas B. Jennings, Craig Logsdon, Robert B. Jaffe, Robert L. Coleman, Anil K. Sood

Clin Cancer Res (2007) 13 (14): 4209–4217.

https://doi.org/10.1158/1078-0432.CCR-07-0197

Published: 18 July 2007

View article titled, Dual Targeting of Endothelial Cells and Pericytes in Antivascular Therapy for Ovarian Carcinoma

Journal Articles

Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy

Jyotsnabaran Halder, Aparna A. Kamat, Charles N. Landen, Jr., Liz Y. Han, Susan K. Lutgendorf, Yvonne G. Lin, William M. Merritt, Nicholas B. Jennings, Arturo Chavez-Reyes, Robert L. Coleman, David M. Gershenson, Rosemarie Schmandt, Steven W. Cole, Gabriel Lopez-Berestein, Anil K. Sood

Clin Cancer Res (2006) 12 (16): 4916–4924.

https://doi.org/10.1158/1078-0432.CCR-06-0021

Published: 16 August 2006

View article titled, Focal Adhesion Kinase Targeting Using <em>In vivo</em> Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy

Journal Articles

Focal Adhesion Kinase Silencing Augments Docetaxel-Mediated Apoptosis in Ovarian Cancer Cells

Jyotsnabaran Halder, Charles N. Landen, Jr., Susan K. Lutgendorf, Yang Li, Nicholas B. Jennings, Dominic Fan, Gina M. Nelkin, Rosemarie Schmandt, Michael D. Schaller, Anil K. Sood

Clin Cancer Res (2005) 11 (24): 8829–8836.

https://doi.org/10.1158/1078-0432.CCR-05-1728

Published: 16 December 2005

View article titled, Focal Adhesion Kinase Silencing Augments Docetaxel-Mediated Apoptosis in Ovarian Cancer Cells

NARROW

Editor's Note: Therapeutic Targeting of ATP7B in Ovarian Carcinoma

Editor's Note: Biologic Effects of Platelet-Derived Growth Factor Receptor α Blockade in Uterine Cancer

Correction: Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability

6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers

Correction: Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy

Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability

Macrophages Facilitate Resistance to Anti-VEGF Therapy by Altered VEGFR Expression

Immunotherapy Targeting Folate Receptor Induces Cell Death Associated with Autophagy in Ovarian Cancer

Biologic Effects of Platelet-Derived Growth Factor Receptor α Blockade in Uterine Cancer

Cross-talk between EphA2 and BRaf/CRaf Is a Key Determinant of Response to Dasatinib

Targeting Src and Tubulin in Mucinous Ovarian Carcinoma

Metronomic Activity of CD44-Targeted Hyaluronic Acid-Paclitaxel in Ovarian Carcinoma

EphA2 Targeted Chemotherapy Using an Antibody Drug Conjugate in Endometrial Carcinoma

Therapeutic Targeting of ATP7B in Ovarian Carcinoma

Estrous Cycle Modulates Ovarian Carcinoma Growth

Surgical Stress Promotes Tumor Growth in Ovarian Carcinoma

Biobehavioral Influences on Matrix Metalloproteinase Expression in Ovarian Carcinoma

Dual Targeting of Endothelial Cells and Pericytes in Antivascular Therapy for Ovarian Carcinoma

Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy

Focal Adhesion Kinase Silencing Augments Docetaxel-Mediated Apoptosis in Ovarian Cancer Cells

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only